Future of legalized cannabis focus of expert panel discussion in cannabis journal

Future of legalized cannabis focus of expert panel discussion in cannabis journal
Cannabis and Cannabinoid Research is the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. Credit: Mary Ann Liebert, Inc., publishers

In the roundtable entitled "Expert Panel on Understanding Cannabis: Medicine, Society, Government," the panelists shared their views on topics ranging from what actions U.S. Attorney General Jeff Sessions might take, the business of growing and selling cannabis, risk of addiction, and whether patients should use cannabis to alleviate cancer pain. The expert Roundtable is published in Cannabis and Cannabinoid Research.

Moderator Kyle Kazan, Co-Founder, AP Investment Fund, led a lively and informative discussion on issues related to cannabis at the interface of , , and government. Bringing to the conversation their broad-ranging knowledge and expertise were panelists Dr. Daniele Piomelli, Professor, University of California, Irvine, School of Medicine; U.S. Rep. Dana Rohrabacher, California's 48th District; and Lori Ajax, Chief, Bureau of Cannabis Control, California Department of Consumer Affairs.

"To fully understand , we must look at it from the different perspectives of medicine, law, and society at large. This roundtable is meant to be a step in that direction," says Editor-in-Chief Daniele Piomelli, PhD, PharmD, University of California-Irvine, School of Medicine.


Explore further

Is cannabis addictive? Are there treatments? Answers in new journal's roundtable discussion

More information: DOI: 10.1089/can.2017.29010.kka
Citation: Future of legalized cannabis focus of expert panel discussion in cannabis journal (2017, September 19) retrieved 19 June 2019 from https://medicalxpress.com/news/2017-09-future-legalized-cannabis-focus-expert.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more